Current Opinion on the Role of Neurogenesis in the Therapeutic Strategies for Alzheimer Disease, Parkinson Disease, and Ischemic Stroke; Considering Neuronal Voiding Function

  

Therapeutic Molecular Insights into the Active Engagement of Cannabinoids in the Therapy of Parkinson’s Disease: A Novel and Futuristic Approach

Vaibhav Jain, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Hafiz A. Makeen, Mohammed Albratty, Abdulkarim M. Meraya, Asim Najmi

Neurotoxicity Research.2023; 41(1): 85.     CrossRef

Impact of Environmental Risk Factors on Mitochondrial Dysfunction, Neuroinflammation, Protein Misfolding, and Oxidative Stress in the Etiopathogenesis of Parkinson’s Disease

Minhong Huang, Alejandra Bargues-Carot, Zainab Riaz, Hannah Wickham, Gary Zenitsky, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, Anumantha G. Kanthasamy

International Journal of Molecular Sciences.2022; 23(18): 10808.     CrossRef

Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment

Saeid Bagheri-Mohammadi

Cell and Tissue Banking.2021; 22(3): 339.     CrossRef

Modeling Neuroregeneration and Neurorepair in an Aging Context: The Power of a Teleost Model

Jolien Van houcke, Valerie Mariën, Caroline Zandecki, Eve Seuntjens, Rajagopal Ayana, Lutgarde Arckens

Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef

The Potential Role of Inflammation in Modulating Endogenous Hippocampal Neurogenesis After Spinal Cord Injury

Arthur Sefiani, Cédric G. Geoffroy

Frontiers in Neuroscience.2021;[Epub]     CrossRef

Vascular Risk Factors and Alzheimer’s Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links

Jin-Ting He, Xin Zhao, Lei Xu, Cui-Ying Mao

Journal of Alzheimer's Disease.2020; 73(1): 39.     CrossRef

Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders

Rúbia W. de Oliveira, Cilene L. Oliveira, Francisco S. Guimarães, Alline C. Campos

Acta Neuropsychiatrica.2019; 31(1): 1.     CrossRef

High-Altitude Cognitive Impairment Is Prevented by Enriched Environment Including Exercise via VEGF Signaling

Christina Koester-Hegmann, Harkaitz Bengoetxea, Dmitry Kosenkov, Markus Thiersch, Thomas Haider, Max Gassmann, Edith M. Schneider Gasser

Frontiers in Cellular Neuroscience.2019;[Epub]     CrossRef

Olfactory bulb atrophy and caspase activation observed in the BACHD rat models of Huntington disease

M. Lessard-Beaudoin, L. Yu-Taeger, M. Laroche, E. Singer, O. Riess, H.H.P. Nguyen, R.K. Graham

Neurobiology of Disease.2019; 125: 219.     CrossRef

Genetic reprogramming of somatic cells into neuroblasts through a co-induction of the doublecortin gene along the Yamanaka factors: A promising approach to model neuroregenerative disorders

Mahesh Kandasamy, Ajisha Yesudhas, G.P. Poornimai Abirami, Risna Kanjirassery Radhakrishnan, Syed Aasish Roshan, Esther Johnson, Vijaya Roobini Ravichandran, Abir Biswas, Sellathamby Shanmugaapriya, Muthuswamy Anusuyadevi, Ludwig Aigner

Medical Hypotheses.2019; 127: 105.     CrossRef

A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases

Jia Zhao, Mengxia Zhu, Mukesh Kumar, Fung Yin Ngo, Yinghui Li, Lixing Lao, Jianhui Rong

CNS & Neurological Disorders - Drug Targets .2019; 18(2): 103.     CrossRef

Cell-based immunofluorescence assay for screening the neurogenesis potential of new drugs in adult hippocampal neural progenitor cells

Kun Zhang, Bin Li, Peifang Li, Xiaoli Yang, Huixian Cui, Xiaoyun Liu

Acta Neurobiologiae Experimentalis.2019; 79(3): 303.     CrossRef

Brain-specific NRSF deficiency aggravates dopaminergic neurodegeneration and impairs neurogenesis in the MPTP mouse model of Parkinson’s disease

Dongping Huang, Qing Li, Yi Wang, Zhaolin Liu, Zishan Wang, Heng Li, Jinghui Wang, Jing Su, Yuanyuan Ma, Mei Yu, Jian Fei, Fang Huang

Aging.2019; 11(10): 3280.     CrossRef

Pharmacological activation of the Nrf2 pathway by 3H-1, 2-dithiole-3-thione is neuroprotective in a mouse model of Alzheimer disease

YuanBo Cui, ShanShan Ma, ChunYan Zhang, DongPeng Li, Bo Yang, PengJu Lv, Qu Xing, Tuanjie Huang, Greta Luyuan Yang, Wei Cao, FangXia Guan

Behavioural Brain Research.2018; 336: 219.     CrossRef

Cerebral Hypoperfusion and Other Shared Brain Pathologies in Ischemic Stroke and Alzheimer’s Disease

Shuying Dong, Shelly Maniar, Mioara D. Manole, Dandan Sun

Translational Stroke Research.2018; 9(3): 238.     CrossRef

Potential for stem cell treatment in manganism

Thatiane C. de Moura, Szeifoul Afadlal, Alan S. Hazell

Neurochemistry International.2018; 112: 134.     CrossRef

The Secretion from Neural Stem Cells Pretreated with Lycopene Protects against tert-Butyl Hydroperoxide-Induced Neuron Oxidative Damage

Cuiqin Huang, Danhui Gan, Chongzhu Fan, Caiyan Wen, An Li, Qin Li, Jiayi Zhao, Zhen Wang, Lihong Zhu, Daxiang Lu

Oxidative Medicine and Cellular Longevity.2018; 2018: 1.     CrossRef

The promoter polymorphism of NFKB1 gene contributes to susceptibility of ischemic stroke in Korean population

Su Kang Kim, Hyang Mi Jang, Dae-Young Kim

Journal of Exercise Rehabilitation.2018; 14(6): 1096.     CrossRef

Differential expression of genes in the subgranular zone and granular cell layer of the hippocampus after running

Hyo-youl Moon

Journal of Exercise Nutrition & Biochemistry.2018; 22(4): 1.     CrossRef

Microglia‐targeted stem cell therapies for Alzheimer disease: A preclinical data review

Zhiwei Shen, Xueyuan Li, Xinjie Bao, Renzhi Wang

Journal of Neuroscience Research.2017; 95(12): 2420.     CrossRef

Neurourological Application of Neurogenesis and Inflammation and Pain Mechanisms of Rocuronium Bromide

Khae Hawn Kim

International Neurourology Journal.2016; 20(4): 274.     CrossRef